GSK plc announced on October 21, 2025, that its Shingrix vaccine's new prefilled syringe design received a positive opinion from the EMA's CHMP, improving administration convenience for healthcare professionals and anticipating EU approval in December 2025; this vaccine prevents shingles, affecting about 1.7 million people in Europe annually.